← AlphaSignal

EW

★★☆☆☆ Passtemplate

Edwards Lifesciences Corporation

Healthcare · sector percentile 17

세션 움직임

$89.28

+$3.54+4.13%

거래량 1.68× 평균

37/100 quant · tgt $100.96

ADV$ 255.7M

세션 2026-09-16 · 스냅샷 — 실시간 호가 아님

직전 스캔 대비

2026-09-15 → 2026-09-16

점수-0.4가격+$0.22 · +0.26%

참고용이며 매수/매도 신호가 아닙니다. 스캔 이력과 캐시된 뉴스·공시로 구성됩니다.

스냅샷 시세

세션 2026-09-16 · 스캔 2026-09-16 · 푸시 09-16 16:00 ET · 애프터아워 (오래됨)

시세 상세 보기
종가/스캔가
$85.74
전일 종가
$85.74
푸시 최신가
$89.31 (오래됨) · 09-16 16:00 ET · 애프터아워
세션 시가
$84.99
직전 세션 범위
$85.49 – $89.70
52주 범위
$81.16 – $93.91
세션 거래량
5,011,448
평균 거래량 (20일)
2,986,047
시가총액
$49.37B
PER (TTM)
51.04
Forward PER
25.39
배당 수익률
0.00%
1년 목표가 추정
$100.96
다음 실적

Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes. 프리/애프터 시세는 유동성이 얇아 정규장과 다를 수 있습니다.

시장 브리핑

선별된 요약입니다 — 매매 신호가 아닙니다. 헤드라인·링크는 제공된 그대로 표시됩니다.

이 종목의 최근 헤드라인이 없습니다.

Price Chart

Daily prices from cache

Loading price history…

AI Analysis

  • Bull Thesis — EW scores 36.59/100 (Pass) with revenue growth at 13.6% and a multi-factor profile supporting the current ranking.
  • Risks — Key risks for EW include valuation compression, sector rotation, and any deterioration in earnings momentum or balance-sheet leverage.
  • Target Upside — Consensus implied upside is 17.8%. Category 'Pass' suggests monitoring position sizing against the 100-point model thresholds.

Score History

2026-08-0636.6 pts · 2026-09-16

30 days of scans. Daily batch adds the next weekday automatically while the API is running.

  • DatePriceChgScoreRating
  • 2026-09-16$85.74+$0.2236.6Pass
  • 2026-09-15$85.52+$1.1537.0Pass
  • 2026-09-14$84.37−$2.4036.2Pass
  • 2026-09-11$86.77+$0.5937.2Pass
  • 2026-09-10$86.18−$0.5436.2Pass
  • 2026-09-09$86.72−$3.1837.3Pass
  • 2026-09-08$89.90$0.0037.8Pass
  • 2026-09-07$89.90+$0.1237.8Pass
  • 2026-09-04$89.78−$1.0437.1Pass
  • 2026-09-03$90.82+$0.0837.8Pass
  • 2026-09-02$90.74−$0.0137.0Pass
  • 2026-09-01$90.75+$0.5436.8Pass
  • 2026-08-31$90.21+$0.2637.5Pass
  • 2026-08-28$89.95−$0.8337.8Pass
  • 2026-08-27$90.78−$0.0937.5Pass
  • 2026-08-26$90.87+$0.3737.1Pass
  • 2026-08-25$90.50+$0.7137.9Pass
  • 2026-08-24$89.79−$0.0439.2Pass
  • 2026-08-21$89.83−$2.4539.3Pass
  • 2026-08-20$92.28+$1.3039.9Pass
  • 2026-08-19$90.98+$0.1739.7Pass
  • 2026-08-18$90.81−$0.7940.6Pass
  • 2026-08-17$91.60−$0.9640.3Pass
  • 2026-08-14$92.56−$0.3840.4Pass
  • 2026-08-13$92.94−$0.7240.4Pass
  • 2026-08-12$93.66+$1.6342.4Pass
  • 2026-08-11$92.03+$2.3141.1Pass
  • 2026-08-10$89.72+$0.4039.4Pass
  • 2026-08-07$89.32+$0.3539.1Pass
  • 2026-08-06$88.9739.3Pass

Quant Breakdown

Revenue Growth
5.4
EPS Growth
0.0
ROE
4.4
PER Relative
0.0
Debt / Equity
8.0
FCF Margin
8.0
Analyst Upside
5.0
Insider / Sector
2.0
Momentum 3M
3.8
Earn. Surprise
0.0

Short volume (FINRA)

Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.

as of 2026-09-16 · finra_cnms
Short / total
49.3%
vs 20d (z)
1.00
Short vol
949,513
Status
ok

Squeeze pressure score

full

68/100

Short leg
66
Call leg
88
Activity
10.0
Call vol share
92.0%
PCR (vol)
0.09
Call OI share
76.8%
ATM IV
46.3%

FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.

공시 점수 (Disclosure)

캐시된 SEC 공시 기반 News / Insider / Earnings 규칙 다리 — 참고용이며, beat/miss나 매수 신호가 아닙니다.

점수 창에 최근 SEC 공시·실적 일정 입력이 아직 없습니다.

Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.

실적 서프라이즈 (퀀트 맥락)

최근 퀀트 스캔에 캐시된 Yahoo/공개 펀더멘털 수치입니다 — 공시 이벤트 점수에 합산되지 않으며 매수 신호가 아닙니다. 최신 발표보다 늦을 수 있습니다.

최근 보고 서프라이즈 -0.3%

Filings & events

Recent SEC disclosures and earnings dates — context only, not a trade signal.

as of 2026-09-14·sec_edgar·CIK 0001099800
Next earnings
2026-10-29yahoo_calendar
Last earnings

SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.